Navigation Links
First Warning Systems Receives Investment by Members of the Reno Angels and Local Investors
Date:8/6/2012

RENO, Nev., Aug. 6, 2012 /PRNewswire/ -- First Warning Systems, Inc. announces members of the Reno Angels have joined together with local investors to invest in the First Warning Systems $1,000,000 Series A funding round. 

Jim Holmes, First Warning's CEO states, "We are approaching fifty percent completion of this Series A round of financing.  We appreciate members of the Reno Angels and local investors' support of the First Warning System." 

For particulars concerning the Series A round, please check First Warning's website: www.firstwarningsystems.com/series-a-funding.html.

The First Warning patented technology uses predictive analytics software to penetrate imaging technology barriers that are limited to viewing a tumor that, on average, has been growing for 11 years.  Deep tissue temperature analysis from 12 hours of dynamic data collection is modeled using predictive analytics software to compare circadian body rhythms that can identify abnormalities up to 6 years prior to imaging technologies. The First Warning product vision video can be seen at www.firstwarningsystems.com

Holmes adds, "We are planning the establishment of a production facility for our products, determining employee requirements to support worldwide marketing and sales.  We are investigating and hopeful of being able to establish these operations in the Truckee Meadows area."        

About First Warning Systems

First Warning Systems, (FWS) founded in 2008, is based in Reno, NV.  FWS' principal shareholder is Lifeline Biotechnologies, Inc. (OTC Market: LLBO). FWS holds the exclusive worldwide license from Lifeline Biotechnologies for development, manufacturing and marketing of the software-based technologies. The FWS product line is a patented device and process that detects breast tissue abnormalities for health risk assessment and management earlier than any other known modalities.  These tissue abnormalities can lead to breast cancers. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes with industry leading 90% accuracy.  FWS is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS predictive analytics product.  FWS is preparing for Euro CE Mark and marketing in the UK, EU and Russian markets.  For more information check www.firstwarningsystems.com

For more information, contact: Jim Holmes, CEO 775-324-3822 or 775-852-3222, jholmes@firstwarningsystems.com 


'/>"/>
SOURCE First Warning Systems, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Chindex International, Inc. Reports Financial Results for the Second Quarter and First Half of 2012
2. Midwest Health Care Startups Raise $511 Million in First Half of 2012
3. OncoGenex Pharmaceuticals, Inc. Reports Second Quarter and First-Half 2012 Financial Results and Reviews Clinical Development Highlights for Custirsen and OGX-427
4. Target for potent first-strike influenza drugs identified
5. Genelex Receives First Patent on Business Methods for Pharmacogenetics
6. TI introduces the industrys first weigh scale and body composition analog front end
7. Midwest Health Care Startups Raise $491 Million in First Half of 2012
8. Uroplasty Reports Fiscal First Quarter 2013 Financial Results
9. Abaxis Reports Financial Performance For The First Quarter Of Fiscal 2013
10. AHIMA Launches First HIM Career Map
11. MIOT Hospital Delivers First TrueBeam STx Radiotherapy Treatment in Chennai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 Dr. Vivek Ahuja , ... Ste phen Schmidt ... provider of cloud-based software solutions for life sciences, today announced key ... a wealth of insight to a growing business.  This will bolster ... George Phillips joined ArisGlobal in the position of Vice ...
(Date:4/28/2016)... , April 28, 2016 ... H1 2016" is a report that provides an ... strengthen R&D pipelines by identifying new targets and ... Company Profiles discussed in this H1 2016 ... Riunite Srl, AbbVie Inc., Abiogen Pharma S.p.A., Ablynx ...
(Date:4/27/2016)... TURIN, Italy , April 27, 2016 ... MR-guided linear accelerator (MR-linac) platform will be the focal ... annual meeting of the European Society for Radiotherapy & ... Elekta,s MR-linac integrates a state-of-the-art radiotherapy system and ... a physician to clearly see the patient,s anatomy in ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... 29, 2016 , ... Reltok Nasal Products proudly announces that Boston Medical Products, ... nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product ... a newly patented safety device secured by nasal surgeons onto the floor of the ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... media enterprise focused entirely on patients with cancer, today announced that Lynne Malestic, ... as the 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors ...
(Date:4/29/2016)... (PRWEB) , ... April 29, 2016 , ... ... and hospice software, outsourced billing and coding services, and Deyta Analytics, recently announced ... hospices providing the highest level of quality as measured from the caregiver’s point ...
(Date:4/29/2016)... ... April 29, 2016 , ... Pro3rd Grunge is a ... Film Studios’ lower thirds to introduce people, characters, and locations without having to set ... lines, accents, textures and many more design components. Simply select a preset and drag ...
(Date:4/28/2016)... ... 2016 , ... Monthly subscription boxes are all the rage, and "My Subscription ... the ZEN BOX , the aromatherapy subscription box. , ZEN BOX delivers three new ... frankincense) and one Zen Blend (like immune boost, sublime sleep or de-stress blends) ...
Breaking Medicine News(10 mins):